Probiotics for patients with liver cirrhosis

Journal of Hepatology

Volumn 49, Issue 6, 2008, Pages 1080-1081

  Fujita, Tetsuji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ENDOTOXIN; INTERLEUKIN 10; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE PANCREATITIS; ALCOHOL LIVER DISEASE; CLINICAL TRIAL; DRUG EFFICACY; ENDOTOXEMIA; GRAM NEGATIVE BACTERIUM; HUMAN; LETTER; LIVER CIRRHOSIS; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

HUMANS; LIVER CIRRHOSIS; NEUTROPHILS; PROBIOTICS;

EID: 55549130229     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.09.006     Document Type: Letter

References (4)

1. Mookerjee R.P., Stadlbauer V., Lidder S., Wright G.A., Hodges S., Davies N.A., et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46 (2007) 831-840
2. Stadlbauer V., Mookerjee R.P., Hodges S., Wright G.A., Davies N.A., and Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 48 (2008) 945-951
3. Riordan S.M., and Williams R. The intestinal flora and bacterial infection in cirrhosis. J Hepatol 45 (2006) 744-757
4. Besselink M.G.H., van Buskens H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659